Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 19/20 | 0.76 |
| ▸ | NPM1 | P06748 | 15/20 | 0.76 |
| ▸ | INSR | P06213 | 12/20 | 0.76 |
| ▸ | JAK2 | O60674 | 2/20 | 0.69 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL520227 | 0.87 | ALK (1.00) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL521665 | 0.85 | ALK (0.78) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL519542 | 0.85 | ALK (1.00) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL519543 | 0.85 | ALK (1.00) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL520249 | 0.85 | ALK (0.82) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL520375 | 0.84 | ALK (1.00) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL16267902 | 0.84 | ALK (0.81) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL519555 | 0.84 | ALK (0.83) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL519554 | 0.84 | ALK (0.83) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL520990 | 0.83 | ALK (1.00) | ALKNPM1INSRJAK2PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376491-A1 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS | Cephalon, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010071885-A1 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS | CEPHALON, INC. (US) | 2010-06-24 | — | — | WO | disclosed |